|
CPT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62647673107585E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-15 |
| Normal-vs-Stage2 |
1.94680005449754E-09 |
| Normal-vs-Stage3 |
3.35469996226578E-09 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
7.213000E-01 |
| Stage1-vs-Stage3 |
4.683000E-01 |
| Stage1-vs-Stage4 |
8.48450000000556E-05 |
| Stage2-vs-Stage3 |
8.077400E-01 |
| Stage2-vs-Stage4 |
7.832500E-02 |
| Stage3-vs-Stage4 |
1.342180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626032641866E-12 |
| Normal-vs-AfricanAmerican |
4.50750547997814E-14 |
| Normal-vs-Asian |
8.921700E-02 |
| Caucasian-vs-AfricanAmerican |
6.450800E-01 |
| Caucasian-vs-Asian |
9.299600E-01 |
| AfricanAmerican-vs-Asian |
8.610000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6269208202857E-12 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
3.813000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.86981549635357E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
2.44249065417534E-15 |
| Normal-vs-Extreme_Obese |
3.093800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.916200E-01 |
| Normal_Weight-vs-Obese |
8.571800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.357900E-02 |
| Extreme_Weight-vs-Obese |
9.643400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.300760E-01 |
| Obese-vs-Extreme_Obese |
6.271700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.76590000003463E-06 |
| Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(81-100Yrs) |
2.37650000001199E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.386200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.148800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.471600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.435400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.219200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.827600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.72710000137621E-08 |
| Normal-VS-KIRP CIMP |
2.98960856071062E-12 |
| Normal-VS-Unclassified PRCC |
1.63413726994577E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.111700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.002000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.148800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.87315999999882E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.022260E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.939520E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.39559996892302E-09 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| Normal-vs-N2 |
1.67539999984534E-07 |
| N0-vs-N1 |
1.130290E-02 |
| N0-vs-N2 |
2.323000E-01 |
| N1-vs-N2 |
5.677800E-01 |
|
|
